L2 DIAGNOSTICS LLC
L2 DIAGNOSTICS LLC is a federal contractor, registered under UEI GKA7VH5LFR25 and CAGE code 43BA5. It has been awarded $50,020,404 in federal contracts. Primary work spans Unknown NAICS, Research and Development in Biotechnology, and Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). Top awarding agencies include Department Of Health And Human Services, Department Of Health And Human Services (hhs), and Department Of Defense.
Contact Information
Registration and classification details
Registration
UEI Code
GKA7VH5LFR25CAGE Code
43BA5Entity Structure
Corporate Entity (Not Tax Exempt)Established
N/ABusiness Classifications
NAICS Codes
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
L2 DIAGNOSTICS LLC specializes in the discovery and validation of novel diagnostic biomarkers for infectious diseases, with a demonstrated focus on malaria through SBIR Phase I research. The company applies advanced biotechnological methodologies to identify and validate molecular signatures that en...
L2 DIAGNOSTICS LLC specializes in the discovery and validation of novel diagnostic biomarkers for infectious diseases, with a demonstrated focus on malaria through SBIR Phase I research. The company applies advanced biotechnological methodologies to identify and validate molecular signatures that enable early, accurate, and field-deployable diagnostic tools. Their technical expertise lies in molecular biology, proteomic and genomic data analysis, assay development, and translational research pathways that bridge laboratory findings to clinical diagnostics. A key differentiator is their targeted approach to neglected tropical disease diagnostics, emphasizing solutions suitable for low-resource settings without relying on nano-biotechnology platforms. The contractor has delivered research services to the Department of Health and Human Services, specifically supporting public health innovation through SBIR-funded programs focused on infectious disease detection. Their engagement with HHS reflects a alignment with NIH and BARDA priorities in advancing point-of-care diagnostics for global health threats. While only one agency is documented, the nature of the award suggests a strategic focus on federal biomedical R&D funding streams aimed at pandemic preparedness and global health equity. L2 DIAGNOSTICS LLC operates primarily under NAICS 541714, which encompasses non-nanobiotechnology research and development in biotechnology, particularly in biomarker identification and diagnostic assay design. Their market positioning is niche but impactful, concentrating on the intersection of infectious disease biology and diagnostic innovation. They are not engaged in broad pharmaceutical development but rather in the early-stage validation of diagnostic targets, filling a critical gap between basic research and commercialization. The entity is structured as a 2L firm based in New Haven, Connecticut, with no public certifications on record. Its small-scale, specialized operations suggest a lean, research-driven model focused on high-value, federally funded SBIR/STTR programs. Geographically, its Connecticut presence situates it within a broader biomedical research corridor, enhancing access to academic and clinical partnerships critical to diagnostic development.
Key Performance Metrics
Awards Count
74
All time
Active
10
Currently performing
Completed
64
Past period of performance
Total Awards
All time
Contracts
Prime · all time
Subcontracts
Sub · all time
Grants
Prime · all time
Subgrants
Sub · all time
Award Analytics & Distribution
Compete with L2 DIAGNOSTICS LLC
Track the contractors you bid against, and the work they win
Award history, agency mix, and NAICS coverage for L2 DIAGNOSTICS LLC
AI-powered matching against your own capabilities and past performance
Teaming and subcontracting signals on every award
Automated alerts when a competitor wins in your market
Join 750+ contractors already using CLEATUS
